SEARCH

SEARCH BY CITATION

References

  • Ahoua L, Guenther G, Pinoges L et al. (2009) Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. BMC Infectious Diseases 9, 81.
  • Anglaret X, Toure S, Gourvellec G et al. (2004) Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes 35, 320323.
  • Auld AF (2009) Treatment Outcomes of HIV-Infected Adults Enrolled in the National Antiretroviral Therapy Program -Mozambique, 2004-2007. HIV/AIDS Implementers’ Meeting Windhoek, Namibia (Abstract 1608).
  • Badri M, Cleary S, Maartens G et al. (2006) When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antiviral Therapy 11, 6372.
  • Bajunirwe F, Arts EJ, Tisch DJ, Debanne SM & Sethi AK (2007) Survival, Adherence to Care and Antiretroviral Treatment (ART) Among HIV-Infected Adults in Rural Western Uganda. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention WEPEB049.
  • Barth RE, Tempelman HA & Hoepelman AIM (2009) Long-Term Follow Up of HIV-Infected Adults in Rural South Africa; Good Virological Results in Spite of Early Mortality. IAS 2009 Cape Town, South Africa (Abstract CDB084).
  • Bisson G, Ndwapi N, Rollins C et al. (2007) High Rates of Death Among Patients Lost to Follow-Up in Botswana’s National Art Program: Implications for Monitoring and Evaluation. 14th Conference on Retroviruses and Opportunistic Infections (CROI) Abstract 537(no poster), Los Angeles.
  • Bisson GP et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS ONE 3, e1725.
  • Boulle A, Bock P, Osler M et al. (2008) Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization 86, 678687.
  • Brinkhof MW, Pujades-Rodriguez M & Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 4, e5790.
  • Bussmann H, Wester CW, Ndwapi N et al. (2008) Five-year outcomes of initial patients treated in Botswana’s National Antiretroviral Treatment Program. AIDS 22, 23032311.
  • Chalamilla G (2008) Predictors of Clinical and Immunological Outcomes among HIV-infected Subjects on ART in Tanzania. 15th Conference on Retroviruses and Opportunistic Infections Abstract 824.
  • Chang LVW, Alamo S, Guma S et al. (2009) Two-Year Virologic Outcomes of an Alternative AIDS Care Model: evaluation of a Peer Health Worker and Nurse-Staffed Community-Based Program in Uganda. Journal of Acquired Immune Deficiency Syndromes 50, 276282.
  • Chi BH, Cantrell RA, Zulu I et al. (2009) Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. International Journal of Epidemiology 38, 746756.
  • Chiliade P (2008) Long-term immunologic outcomes of patients started on antiretroviral therapy in 2 Sub-Saharan resource-limited countries. XVII International AIDS Conference CDB0233.
  • Coetzee D, Hildebrand K, Boulle A et al. (2004) Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18, 887895.
  • Collini P, Schwab U, Sarfo S et al. (2009) Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort. Clinical Infectious Diseases 48, 988991.
  • Culbert H, Tu D, O’Brien DP et al. (2007) HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo. PLoS Medicine 4, e129.
  • Dahab M (2008) Off the radar screen: comparing reasons for treatment default in a workplace ART programme and a public sector clinic in South Africa. XVII International AIDS Conference THPE0123.
  • DeSilva MB, Merry SP, Fischer PR et al. (2009) Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria. Aids Care-Psychological and Socio-Medical Aspects of Aids/HIV 21, 7077.
  • Egger M, Davey Smith G & Altman DG (2001) Systematic Reviews in Health Care: Meta-analysis in Context, 2nd edn. BMJ Books, London.
  • Egger M, May M, Chene G et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360, 119129.
  • Fairall LR, Bachmann MO, Louwagie GM et al. (2008) Effectiveness of antiretroviral treatment in a South African program: a cohort study. Archives of Internal Medicine 168, 8693.
  • Fox MP, Brennan A, Maskew M et al. (2010) Using Vital Registration Data to Update Mortality among Patients Lost to Follow-up from ART Programs: Evidence from the Themba Lethu Clinic, South Africa. Tropical Medicine and International Health 15, 405413.
  • Freeman MF & Tukey JW (1950) Transformations related to the angular and the square root. Annals of the Institute of Statistical Mathematics 21, 607611.
  • Geng EH, Emenyonu N, Bwana MB, Glidden DV & Martin JN (2008) Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Grimwood A (2008) Public-private partnership achieves long-term ARV adherence in South Africa. XVII International AIDS Conference CDB0221.
  • Gugsa S (2008) Determinants of retention and mortality during 6-month follow-up after initiation of HAART in an Ethiopian public HIV treatment program. XVII International AIDS Conference CDB0246.
  • Ivers LC, Kendrick D & Doucette K (2005) Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clinical Infectious Diseases 41, 217224.
  • Jahn A (2008) Antiretroviral regimen substitutions and switches due to drug toxicity and treatment failure: a national survey three years after the start of antiretroviral therapy roll-out in Malawi. XVII International AIDS Conference MOPE0044.
  • Johannessen A, Naman E, Ngowi BJ et al. (2008) Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infectious Diseases 8, 52.
  • Kaplan R, Orrell C, Zwane E, Bekker LG & Wood R (2008) Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS 22, 16791681.
  • Keiser O, Anastos K, Schechter M et al. (2008) Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Tropical Medicine and International Health 13, 870879.
  • Khan MSH (2009) Retention and Attrition of Patients Commenced on HAART at Ladysmith Provincial Hospital in South Africa. IAS 2009 Cape Town, South Africa (Abstract MOPEB045).
  • Laurent C, Ngom Gueye NF, Ndour CT et al. (2005) Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. Journal of Acquired Immune Deficiency Syndromes 38, 1417.
  • Lawn SD, Myer L & Wood R (2005) Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world? Clinical Infectious Diseases 41, 16831684.
  • Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 18971908.
  • Lowrance DW, Ndamage F, Kayirangwa E et al. (2009) Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004–2005. Journal of Acquired Immune Deficiency Syndromes 52, 4955.
  • MacPherson P, Moshabela M, Martinson N & Pronyk P (2009) Mortality and loss to follow-up among HAART initiators in rural South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 103, 588593.
  • Marazzi MC, Liotta G, Germano P et al. (2008) Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Research and Human Retroviruses 24, 555560.
  • Martin J (2008) Initial Treatment Outcomes from a Rural-based ART Scale-up Program in East Africa: The UARTO Cohort. 15th Conference on Retroviruses and Opportunistic Infections Abstract 816.
  • Mocroft AJ, Lundgren JD, d’Armino MA et al. (1997) Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. International Journal of Epidemiology 26, 400407.
  • Morgan D, Mahe C, Mayanja B et al. (2002) HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 16, 597603.
  • Nachega JB, Hislop M, Dowdy DW et al. (2008) Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS 22, 21172125.
  • O’Brien DP, Mills C, Hamel C, Ford N & Pottie K (2009) Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo. Conflict and Health 3, 1.
  • Ojikutu BO, Zheng H, Walensky RP et al. (2008) Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. South African Medical Journal 98, 204208.
  • Palombi L, Marazzi MC, Guidotti G et al. (2009) Incidence and Predictors of Death, Retention, and Switch to Second-Line Regimens in Antiretroviral-Treated Patients in Sub-Saharan African Sites with Comprehensive Monitoring Availability. Clinical Infectious Diseases 48, 115122.
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Medicine 4, e298.
  • Rosen S, Long L & Sanne I (2008) The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Tropical Medicine and International Health 13, 10051015.
  • Sieleunou I, Souleymanou M, Schonenberger AM, Menten J & Boelaert M (2009) Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Tropical Medicine and International Health 14, 3643.
  • Souteyrand Y, Akwara P, Warner Smith M et al. (2009) Scaling up access to antiretroviral therapy (ART) in low- and middle-income countries: global and regional progress in 2008. International AIDS Society Conference WELBD105.
  • Toure S, Kouadio B, Seyler C et al. (2008) Rapid scaling-up of antiretroviral therapy in 10000 adults in Cote d’Ivoire: 2-year outcomes and determinants. AIDS 22, 873882.
  • Unge C, Sodergard B, Ekstrom AM et al. (2009) Challenges for scaling up ART in a resource-limited setting: a retrospective study in kibera, Kenya. Jaids-Journal of Acquired Immune Deficiency Syndromes 50, 397402.
  • Yiannoutsos CT, An MW, Frangakis CE et al. (2008) Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE 3, e3843.